AI assistant
Sending…
ABBOTT LABORATORIES — Director's Dealing 2007
Dec 4, 2007
29777_dirs_2007-12-04_f467d78c-0374-462f-9af7-6ba873d7222a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2007-11-30
Reporting Person: LINDER GREG W (Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2007-11-30 | Common shares without par value | M | 52312 | $45.4488 | Acquired | 181425 | Direct |
| 2007-11-30 | Common shares without par value | F | 45893 | $57.00 | Disposed | 135532 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2007-11-30 | Option (right to buy) | $45.4488 | M | 52312 | Disposed | 2011-02-08 | common shares (52312) | Direct |
| 2007-11-30 | Option (right to buy) | $57.00 | A | 45893 | Acquired | 2011-02-08 | common shares (45893) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common shares without par value | 12473 | Indirect |
Footnotes
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of November 30, 2007.
F2: Employee stock option including a replacement option feature granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
More from ABBOTT LABORATORIES
Regulatory Filings
2026
Jul 16
Annual Report
2026
Jun 18
Regulatory Filings
2026
May 27
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Board/Management Information
2026
Apr 27
Regulatory Filings
2026
Apr 24
Legal Proceedings Report
2026
Apr 17
Call Transcript
2026
Apr 16
Earnings Release
2026
Apr 16